Skip to main content
    V

    Varex Imaging Corp (VREX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $18.39
    -0.08 (-0.43%)

    Market Cap: $784.30M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(26/39)
    Avg Surprise
    +24.51%
    Streak
    8 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.31
    Range$-0.05 - $0.51
    3 analysts
    Revenue Consensus
    $226M
    Range$223M - $229M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.18
    Range$0.18 - $0.18
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.20-10.0%
    60d ago$0.20-10.0%
    30d ago$0.20-10.0%
    7d ago$0.17+2.9%
    Current$0.18
    Revenue Consensus
    $218M
    Range$218M - $218M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.18---
    Sep 26EST
    		-$0.31---
    Jun 26
    Reported Aug 10
    		$0.31$0.22+40.91%Beat+72.2%
    Mar 26
    Reported May 7
    		$0.21$0.21+0.00%Beat-19.2%
    Dec 25
    Reported Feb 10
    		$0.19$0.13+46.15%Beat+171.4%
    Sep 25
    Reported Nov 18
    		$0.37$0.18+105.56%Beat+94.7%
    Jun 25
    Reported Aug 7
    		$0.18$0.04+350.00%Beat+28.6%
    Mar 25
    Reported May 8
    		$0.26$0.14+85.71%Beat+62.5%
    Dec 24
    Reported Feb 6
    		$0.07$0.04+75.00%Beat+16.7%
    Sep 24
    Reported Nov 19
    		$0.19$0.09+111.11%Beat-57.8%
    Jun 24
    Reported Aug 1
    		$0.14$0.19-26.32%Miss-62.2%
    Mar 24
    Reported May 2
    		$0.16$0.21-23.81%Miss-38.5%
    Dec 23
    Reported Feb 6
    		$0.06$0.11-45.45%Miss-71.4%
    Sep 23
    Reported Nov 14
    		$0.45$0.35+28.57%Beat+7.1%
    Jun 23
    Reported Aug 1
    		$0.37$0.32+15.63%Beat+0.0%
    Mar 23
    Reported May 2
    		$0.26$0.18+44.44%Beat-29.7%
    Dec 22
    Reported Jan 31
    		$0.21$0.19+10.53%Beat-16.0%
    Sep 22
    Reported Nov 15
    		$0.42$0.36+16.67%Beat-6.7%
    Jun 22
    Reported Aug 2
    		$0.37$0.25+48.00%Beat-7.5%
    Mar 22
    Reported May 3
    		$0.37$0.23+60.87%Beat+5.7%
    Dec 21
    Reported Feb 8
    		$0.25$0.28-10.71%Miss+212.5%
    Sep 21
    Reported Nov 16
    		$0.45$0.37+21.62%Beat+1225.0%
    Jun 21
    Reported Aug 3
    		$0.40$0.27+48.15%Beat+300.0%
    Mar 21
    Reported May 4
    		$0.35$0.16+118.75%Beat+191.7%
    Dec 20
    Reported Feb 4
    		$0.08$-0.03+366.67%Beat-61.9%
    Sep 20
    Reported Nov 17
    		$-0.04N/A+60.00%Beat-108.7%
    Jun 20
    Reported Aug 12
    		$-0.20$0.07-385.71%Miss-183.3%
    Mar 20
    Reported May 12
    		$0.12N/A-65.71%Miss-64.7%
    Dec 19
    Reported Feb 11
    		$0.21$0.26-19.23%Miss-19.2%
    Sep 19
    Reported Nov 12
    		$0.46$0.44+4.55%Beat+58.6%
    Jun 19
    Reported Aug 6
    		$0.24$0.34-29.41%Miss-29.4%
    Mar 19
    Reported May 7
    		$0.34$0.34+0.00%Beat-24.4%
    Dec 18
    Reported Feb 5
    		$0.26$0.25+4.00%Beat+13.0%
    Sep 18
    Reported Nov 13
    		$0.29$0.30-3.33%Miss-50.8%
    Jun 18
    Reported Aug 2
    		$0.34$0.51-33.33%Miss-22.7%
    Mar 18
    Reported May 3
    		$0.45$0.45+0.00%Beat+12.5%
    Dec 17
    Reported Feb 1
    		$0.23$0.41-43.90%Miss-23.3%
    Sep 17
    Reported Nov 9
    		$0.59$0.54+9.26%Beat-
    Jun 17
    Reported Aug 3
    		$0.44$0.46-4.35%Miss-
    Mar 17
    Reported May 4
    		$0.40$0.38+5.26%Beat-
    Dec 16
    Reported Jan 20
    		$0.30$0.43-30.23%Miss-

    Key Metrics

    Valuation
    P/E Ratio17.03EV/EBITDA11.06x
    Price/FCF-38.33xFCF Yield-2.61%
    Profitability
    Profit Margin2.56%Operating Margin10.80%
    ROE4.59%ROIC6.12%
    Financial Health
    Debt/Equity0.70xInterest Coverage1.64x
    Current Ratio3.38xQuick Ratio1.53x
    Trading Statistics
    Beta0.97Avg Volume538.27K
    52-Week High$18.6352-Week Low$9.09

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$18.46
    SMA 20$18.47
    SMA 50$18.11
    SMA 200$13.25
    EMA 10$18.45
    EMA 20$18.40
    EMA 50$17.34
    EMA 200$13.85

    MACD

    Line: 0.18Signal: 0.27Hist: -0.09

    ADX

    ADX: 55.0+DI: 28.6-DI: 19.2

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down100.0
    PSAR$18.49

    Bollinger Bands

    Upper Band$18.52
    Lower Band$18.41
    %B Position61%(Middle)
    Band Width-0.18

    RSI (14-Day)

    Neutral
    62.4

    Momentum Oscillators

    Stoch %K49.8
    Stoch %D56.3
    Williams %R-88.0
    ROC (10d)-0.3%
    Momentum-0.06
    CCI (20d)-268.6
    MFI (14d)42.8

    Volatility Measures

    ATR (14d)$0.08(0.4%)
    StdDev (20d)0.03
    Hist Vol3.0%(Low)

    Volume Flow

    VWAP$18.41
    OBV31.5M
    AD Line4.2M
    CMF (20d)-0.174

    Volume Metrics

    Avg Vol (20d)531.1K
    Vol Ratio1.6x(High)
    VWMA (20d)$18.47

    Pivot Points

    R3$18.52
    R2$18.50
    R1$18.49
    Pivot Point$18.47
    S1$18.46
    S2$18.44
    S3$18.43

    Advanced Oscillators

    TSI48.12
    Ultimate Osc41.4
    KST-1.18

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$210.50M$216.00M$209.60M$228.90M$203.00M$212.90M$199.80M$205.70M$209.10M$206.20M$190.00M$227.40M
    Cost of Revenue$133.80M$143.40M$139.80M$151.10M$135.50M$136.20M$131.30M$138.60M$142.20M$140.40M$132.90M$149.40M
    Gross Profit$76.70M$72.60M$69.80M$77.80M$67.50M$76.70M$68.50M$67.10M$66.90M$65.80M$57.10M$78.00M
    Operating Expenses$53.90M$58.20M$54.40M$58.20M$148.20M$54.60M$57.30M$56.20M$57.60M$58.10M$52.90M$53.70M
    R&D$23.30M$22.20M$21.70M$24.20M$21.40M$22.00M$23.50M$21.90M$22.00M$22.60M$20.50M$21.80M
    SG&A$30.60M$36.00M$32.70M$34.00M$32.90M$32.60M$33.80M$34.30M$35.60M$35.50M$32.40M$31.90M
    Operating Income$22.80M$14.40M$15.40M$19.60M$-80,700,000$22.10M$11.20M$10.90M$9.30M$7.70M$4.20M$24.30M
    Interest Income$900,000$400,000$600,000$1.00M$2.50M$2.90M$2.10M$1.80M$1.80M$1.80M$1.90M$1.60M
    Interest Expense$5.80M$17.20M$7.90M$7.90M$9.40M$10.20M$8.00M$7.60M$7.40M$7.90M$7.30M$7.20M
    Income Before Tax$16.20M$-6,400,000$3.80M$14.10M$-86,600,000$10.80M$2.50M$2.50M$800,000$2.30M$-600,000$1.00M
    Income Tax Expense$300,000$1.60M$1.40M$1.90M$2.50M$3.70M$2.60M$53.50M$-700,000$700,000$-200,000$-30,200,000
    Net Income$15.90M$-8,000,000$2.40M$12.20M$-89,100,000$7.10M$-100,000$-51,000,000$1.50M$1.60M$-400,000$31.20M
    EBITDA$28.40M$17.50M$18.40M$28.10M$-72,200,000$25.50M$16.30M$15.60M$14.20M$17.80M$14.20M$16.10M
    EBIT$21.10M$10.40M$11.10M$21.00M$-79,700,000$18.10M$8.40M$8.30M$6.40M$8.40M$4.80M$6.60M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about VREX

    Government Contracts

    Gov Obligations (TTM)
    $9.02M
    Gov Obligations / Revenue
    1.1%
    Obligations YoY
    123.7%
    Active Awards
    14
    New Awards (TTM)
    9
    Avg Remaining Term
    9.3 mo

    Top agency: Department of Homeland Security at 68.7% of trailing twelve month obligations across 4 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    N6833525F0443Department of DefenseDepartment of the Navy$1.82MSep 18, 2025
    80TECH25P0007National Aeronautics and Space AdministrationNational Aeronautics and Space Administration$319745Sep 23, 2025
    W519TC26PA121Department of DefenseDepartment of the Army$221885Mar 31, 2026
    N0038325PP223Department of DefenseDepartment of the Navy$95064Aug 5, 2025
    SPE4A626PE052Department of DefenseDefense Logistics Agency$32200Feb 4, 2026
    SPE4A626V6190Department of DefenseDefense Logistics Agency$14224Jan 6, 2026
    9531BM26F0010National Transportation Safety BoardNational Transportation Safety Board$4972Dec 1, 2025
    SPE4A526P2883Department of DefenseDefense Logistics Agency$4865Feb 6, 2026
    9531BM26F0013National Transportation Safety BoardNational Transportation Safety Board$1674Jan 12, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Two grants of 5,411 stock units each go to Varex Imaging (VREX) legal chief Matthew Aaron Martinez.

    Varex Imaging's Chief Legal Officer, Matthew Aaron Martinez, received two direct awards of 5,411 restricted stock units (RSUs) on October 12, 2026. These RSUs have different vesting schedules...

    Stock Titan•10/15/26•Neutral

    The Technical Signals Behind (VREX) That Institutions Follow

    This article provides a technical analysis of Varex Imaging Corporation (NASDAQ: VREX), detailing key findings such as neutral near and mid-term readings but a positive long-term bias. It outlines institutional trading...

    Stock Traders Daily•10/15/26•Neutral

    Form 4 Varex Imaging Corp: Matthew Aaron Martinez (CLO) For: 12 October

    This article reports on a Form 4 filing for Varex Imaging Corp, detailing a transaction by Matthew Aaron Martinez, the Chief Legal Officer (CLO), on October 12. The filing indicates insider activity for the company...

    Investing.com India•10/14/26•Neutral

    Form 4 Varex Imaging Corp: Matthew Aaron Martinez (CLO) For: 12 October

    This article reports on a Form 4 filing for Varex Imaging Corp, detailing a transaction involving Matthew Aaron Martinez, the company's CLO...

    Investing.com Nigeria•10/14/26•Neutral

    Form 4 Varex Imaging Corp For: Oct 12 Filed by: Martinez Matthew Aaron

    Matthew Aaron Martinez, Chief Legal Officer of Varex Imaging Corp (VREX), filed a Form 4 detailing derivative securities transactions on October 12...

    StreetInsider•10/14/26•Neutral

    VREX Valuation and Fair Value

    P/E
    17.0x
    Forward P/E
    20.3x
    EV/EBITDA
    11.1x
    P/FCF
    -38.3x
    PEG
    5.0x
    P/B
    1.6x
    See GNG's fair value

    VREX Profitability: Margins, ROIC and FCF

    Gross margin
    34.3%
    Operating margin
    10.8%
    Net margin
    2.6%
    ROIC
    6.1%
    ROE
    4.6%
    FCF margin
    -2.3%
    FCF yield
    -2.6%

    VREX Competitors

    CompanyTicker
    Corvus Pharmaceuticals IncCRVS
    Geron CorporationGERN
    Ginkgo Bioworks HoldingsDNA
    Candel Therapeutics IncCADL
    Esperion Therapeutics IncESPR
    Enhabit Inc.EHAB
    Ardelyx IncARDX
    Immix Biopharma IncIMMX

    Sector: Healthcare

    VREX Analyst Ratings

    Consensus
    Hold
    Analysts
    4
    Strong Buy
    0
    Buy
    0
    Hold
    4
    Sell
    0
    Strong Sell
    0

    VREX Bull Case vs Bear Case

    Bull case

    • VREX beat EPS estimates in 87.5% of its last 8 reported quarters.

    VREX Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    101.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.31

    Frequently Asked Questions About VREX

    Does VREX pay dividends?

    Varex Imaging Corp (VREX) does not currently pay a regular dividend.

    What is VREX's P/E ratio?

    Varex Imaging Corp has a price-to-earnings (P/E) ratio of 17.03.

    What is VREX's market cap?

    Varex Imaging Corp (VREX) has a market capitalization of $784.30M with a current stock price of $18.39.

    Related stocks

    Sector: Healthcare

    All stocks starting with V

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In